RichardEugeneNelsonMD

PubMed

• Attributable Cost and Length of Stay Associated with Nosocomial Gram-Negative Bacterial Cultures
  Richard E Nelson, Eli N Perencevich> ;Antimicrobial Agents and Chemotherapy.
• ATTRIBUTABLE COST AND LENGTH OF STAY OF NOSOCOMIAL GRAM-NEGATIVE BACTERIA CULTURES.
  Nelson, R. E.,Stevens, V. W.,Jones, M.,Khader, K.,Schweizer, M. L.,Perencevich, E. N.,Rubin, M. A.,Samore, M. H.> ;Antimicrob. Agents Chemother.. 2018 Aug 29
• Dynamic transmission models for economic analysis applied to health care-associated infections: A review of the literature.
  Nelson, R. E.,Deka, R.,Khader, K.,Stevens, V. W.,Schweizer, M. L.,Rubin, M. A.> ;Am J Infect Control. 2017 Sep 30
• Economic Analysis of Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus Aureus Infections
  Richard E Nelson, Michael A Rubin, Makoto Jones> ;American Journal of Preventive Medicine. 2016 Apr 23
• Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
  Bellows BK, Nelson RE, Oderda GM, LaFleur J> ;Pain. 2016-01-01
• Analysis of osteoporosis treatment patterns with bisphosphonates and outcomes among postmenopausal veterans.
  LaFleur J, DuVall SL, Willson T, Ginter T, Patterson O, Cheng Y, Knippenberg K, Haroldsen C, Adler RA, Curtis JR, Agodoa I, Nelson RE> ;Bone. 2015-09-01
• Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans.
  Nelson RE, Xie Y, DuVall SL, Butler J, Kamauu AWC, Knippenberg K, Schuerch M, Foskett N, LaFleur J> ;Int J MS Care. 2015-01-01
• Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009.
  Gundlapalli AV, Nelson RE, Haroldsen C, Carter ME, LaFleur J> ;PLoS ONE. 2015-01-01
• Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy.
  Nelson RE, Hoop R, Korner E, DuVall S, Hayden CL, Knippenberg K, Morgan T, Pandya P, Han J, LaFleur J> ;Ann Pharmacother. 2014-07-01
• Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis.
  Nelson, R. E.,Nebeker, J. R.,Hayden, C.,Reimer, L.,Kone, K.,LaFleur, J.> ;AIDS Behav. 2012 Aug 08
• Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture.
  Nelson, R.E., Nebeker, J.R., Sauer, B.C., Lafleur, J.> ;Bone. 2012 Apr
• Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension.
  Lafleur, J., Nelson, R.E., Sauer, B.C., Nebeker, J.R.> ;Heart. 2011 Nov
• The benefits and risks of new therapies for type 2 diabetes.
  Asche, C.V., Nelson, R.E.> ;J Manag Care Pharm. 2008 Sep
• Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.
  Jackson, K.C., Sheng, X., Nelson, R.E., Keskinaslan, A., Brixner, D.I.> ;Clin Ther. 2008-08-01
• The effect of increased travel reimbursement rates on health care utilization in the VA.
  Nelson, R. E.,Hicken, B.,West, A.,Rupper, R.> ;J Rural Health. 2012 Mar 31
• The cost-effectiveness of telestroke in the treatment of acute ischemic stroke.
  Nelson, R. E., Saltzman, G. M., Skalabrin, E. J., Demaerschalk, B. M., Majersik, J. J.> ;Neurology. 2011 Oct 25
• Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers.
  Nelson, R. E., Samore, M. H., Smith, K. J., Harbarth, S., Rubin, M. A.> ;Clin Microbiol Infect. 2010 Dec
• Validated risk rule using computerized data to identify males at high risk for fracture.
  LaFleur, J., Nelson, R. E., Yao, Y., Adler, R. A., Nebeker, J. R.> ;Osteoporos Int. 2012 Mar
• Testing the Fetal Origins Hypothesis in a developing country: evidence from the 1918 Influenza Pandemic.
  Nelson, R. E.> ;Health Econ. 2010 Oct 01
• Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations.
  Brixner, D. I., Jackson, K. C., Sheng, X., Nelson, R. E., Keskinaslan, A.> ;Curr Med Res Opin. 2008 Sep 01
• Patent extension policy for paediatric indications: an evaluation of the impact within three drug classes in a state Medicaid programme.
  Nelson, R. E., McAdam-Marx, C., Evans, M. L., Ward, R., Campbell, B., Brixner, D., Lafleur, J.> ;Appl Health Econ Health Policy. 2011 May 1
• The impact of mental illness on the risk of employment termination.
  Nelson, R. E., Kim, J.> ;J Ment Health Policy Econ. 2011 Mar
• Join now to see all